Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Clinical and Translational Science|October 27, 2019
Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration-QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy VolunteersAndreas Becker, Emily C Martin, David Y Mitchell, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
Ets-1 maintains IL-7 receptor expression in peripheral T cellsRoland Grenningloh, Tzong-Shyuan Tai, Nicole Frahm, et al.Molecular Pharmacology|January 8, 2017
Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor SignalingAndrew T Bender, Anna Gardberg, Albertina Pereira, et al.Brain : a Journal of Neurology|March 16, 2021
Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibitionPavan Bhargava, Sol Kim, Arthur A Reyes, et al.European Journal of Immunology|February 4, 2010
SUMOylation attenuates c-Maf-dependent IL-4 expressionBo-Shiou Lin, Pei-Yun Tsai, Wan-Yun Hsieh, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Efficient recruitment of lymphocytes in inflamed brain venules requires expression of cutaneous lymphocyte antigen and fucosyltransferase-VIILaura Piccio, Barbara Rossi, Lucia Colantonio, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease ModelsPhilipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, et al.Bioorganic & Medicinal Chemistry Letters|October 7, 2018
Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of BtkRichard Caldwell, Lesley Liu-Bujalski, Hui Qiu, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammationDaniel C Kim, F Ida Hsu, Nora A Barrett, et al.Bioorganic & Medicinal Chemistry Letters|August 21, 2018
Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hitHui Qiu, Lesley Liu-Bujalski, Richard D Caldwell, et al.Pageof 3